Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

FDA Approves Subcutaneous C1 Esterase Inhibitor to Treat Rare Genetic Disease

americanpharmaceuticalreviewJune 27, 2017

Tag: FDA , C1 Esterase Inhibitor , Rare Genetic Disease

PharmaSources Customer Service